BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shahmirzadi L, Chao EC, Palmaer E, Parra MC, Tang S, Gonzalez KD. Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing. Genet Med 2014;16:395-9. [PMID: 24113345 DOI: 10.1038/gim.2013.153] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Rost C, Dent KM, Botkin J, Rothwell E. Experiences and lessons learned by genetic counselors in returning secondary genetic findings to patients. J Genet Couns 2020;29:1234-44. [PMID: 32453499 DOI: 10.1002/jgc4.1292] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
2 Hicks JK, Shealy A, Schreiber A, Coleridge M, Noss R, Natowicz M, Moran R, Moss T, Erwin A, Eng C. Patient Decisions to Receive Secondary Pharmacogenomic Findings and Development of a Multidisciplinary Practice Model to Integrate Results Into Patient Care. Clin Transl Sci 2018;11:71-6. [PMID: 28749586 DOI: 10.1111/cts.12493] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Rego S, Dagan-Rosenfeld O, Bivona SA, Snyder MP, Ormond KE. Much ado about nothing: A qualitative study of the experiences of an average-risk population receiving results of exome sequencing. J Genet Couns 2019;28:428-37. [PMID: 30835913 DOI: 10.1002/jgc4.1096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
4 Cléophat JE, Dorval M, El Haffaf Z, Chiquette J, Collins S, Malo B, Fradet V, Joly Y, Nabi H. Whether, when, how, and how much? General public's and cancer patients' views about the disclosure of genomic secondary findings. BMC Med Genomics 2021;14:167. [PMID: 34174888 DOI: 10.1186/s12920-021-01016-8] [Reference Citation Analysis]
5 Horiuchi Y, Matsubayashi H, Kiyozumi Y, Nishimura S, Higashigawa S, Kado N, Nagashima T, Mizuguchi M, Ohnami S, Arai M, Urakami K, Kusuhara M, Yamaguchi K. Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients. Hum Genet 2021;140:321-31. [PMID: 32710294 DOI: 10.1007/s00439-020-02207-6] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Raghuram Pillai P, Prows CA, Martin LJ, Myers MF. Decisional conflict among adolescents and parents making decisions about genomic sequencing results. Clin Genet 2020;97:312-20. [PMID: 31654527 DOI: 10.1111/cge.13658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hegde M, Bale S, Bayrak-Toydemir P, Gibson J, Jeng LJ, Joseph L, Laser J, Lubin IM, Miller CE, Ross LF, Rothberg PG, Tanner AK, Vitazka P, Mao R. Reporting incidental findings in genomic scale clinical sequencing--a clinical laboratory perspective: a report of the Association for Molecular Pathology. J Mol Diagn 2015;17:107-17. [PMID: 25684271 DOI: 10.1016/j.jmoldx.2014.10.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 5.9] [Reference Citation Analysis]
8 Roche MI, Berg JS. Incidental Findings with Genomic Testing: Implications for Genetic Counseling Practice. Curr Genet Med Rep 2015;3:166-76. [PMID: 26566463 DOI: 10.1007/s40142-015-0075-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 8.1] [Reference Citation Analysis]
9 Shickh S, Clausen M, Mighton C, Gutierrez Salazar M, Zakoor KR, Kodida R, Reble E, Elser C, Eisen A, Panchal S, Aronson M, Graham T, Armel SR, Morel CF, Fattouh R, Glogowski E, Schrader KA, Hamilton JG, Offit K, Robson M, Carroll JC, Isaranuwatchai W, Kim RH, Lerner-Ellis J, Thorpe KE, Laupacis A, Bombard Y; Incidental Genomics Study Team. Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial. BMJ Open 2019;9:e031092. [PMID: 31594892 DOI: 10.1136/bmjopen-2019-031092] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
10 Swanson K, Sparks TN, Lianoglou BR, Chen F, Downum S, Patel S, Rego S, Yip T, Van Ziffle J, Koenig BA, Slavotinek AM, Norton ME. Preference for secondary findings in prenatal and pediatric exome sequencing. Prenat Diagn 2021. [PMID: 34057224 DOI: 10.1002/pd.5973] [Reference Citation Analysis]
11 Fiore RN, Goodman KW. Precision medicine ethics: selected issues and developments in next-generation sequencing, clinical oncology, and ethics. Curr Opin Oncol 2016;28:83-7. [PMID: 26569425 DOI: 10.1097/CCO.0000000000000247] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
12 Ralefala D, Kasule M, Wonkam A, Matshaba M, de Vries J. Should Feedback of Individual Results be Integrated into the Consent Process in African Genomics? Participants' Views from an HIV-TB Genomics Research Project in Botswana. AJOB Empir Bioeth 2021;:1-9. [PMID: 34197280 DOI: 10.1080/23294515.2021.1941414] [Reference Citation Analysis]
13 Kassahn KS, Scott HS, Caramins MC. Integrating massively parallel sequencing into diagnostic workflows and managing the annotation and clinical interpretation challenge. Hum Mutat 2014;35:413-23. [PMID: 24510514 DOI: 10.1002/humu.22525] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
14 Blackburn HL, Schroeder B, Turner C, Shriver CD, Ellsworth DL, Ellsworth RE. Management of Incidental Findings in the Era of Next-generation Sequencing. Curr Genomics 2015;16:159-74. [PMID: 26069456 DOI: 10.2174/1389202916666150317232930] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
15 Kaphingst KA, Ivanovich J, Biesecker BB, Dresser R, Seo J, Dressler LG, Goodfellow PJ, Goodman MS. Preferences for return of incidental findings from genome sequencing among women diagnosed with breast cancer at a young age. Clin Genet 2016;89:378-84. [PMID: 25871653 DOI: 10.1111/cge.12597] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
16 Godino L, Varesco L, Bruno W, Bruzzone C, Battistuzzi L, Franiuk M, Miccoli S, Bertonazzi B, Graziano C, Seri M, Turchetti D. Preferences of Italian patients for return of secondary findings from clinical genome/exome sequencing. J Genet Couns 2021;30:665-75. [PMID: 33142017 DOI: 10.1002/jgc4.1350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Schupmann W, Miner SA, Sullivan HK, Glover JR, Hall JE, Schurman SH, Berkman BE. Exploring the motivations of research participants who chose not to learn medically actionable secondary genetic findings about themselves. Genet Med 2021. [PMID: 34326490 DOI: 10.1038/s41436-021-01271-1] [Reference Citation Analysis]
18 Bijlsma RM, Bredenoord AL, Gadellaa-Hooijdonk CG, Lolkema MP, Sleijfer S, Voest EE, Ausems MG, Steeghs N. Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsidered. Eur J Hum Genet 2016;24:1496-500. [PMID: 27071717 DOI: 10.1038/ejhg.2016.27] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
19 Levenson D. Patients and families generally welcome secondary genomic findings: support for return of incidental findings may encourage shift toward predictive genetic testing. Am J Med Genet A 2014;164A:ix-x. [PMID: 24449202 DOI: 10.1002/ajmg.a.36418] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Smith EE, du Souich C, Dragojlovic N, Elliott AM; CAUSES Study, RAPIDOMICS Study. Genetic counseling considerations with rapid genome-wide sequencing in a neonatal intensive care unit. J Genet Couns 2019;28:263-72. [DOI: 10.1002/jgc4.1074] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
21 Roche MI, Griesemer I, Khan CM, Moore E, Lin FC, O'Daniel JM, Foreman AKM, Lee K, Powell BC, Berg JS, Evans JP, Henderson GE, Rini C. Factors influencing NCGENES research participants' requests for non-medically actionable secondary findings. Genet Med 2019;21:1092-9. [PMID: 30237575 DOI: 10.1038/s41436-018-0294-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
22 Shen T, Lee A, Shen C, Lin CJ. The long tail and rare disease research: the impact of next-generation sequencing for rare Mendelian disorders. Genet Res (Camb) 2015;97:e15. [PMID: 26365496 DOI: 10.1017/S0016672315000166] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
23 Chassagne A, Pélissier A, Houdayer F, Cretin E, Gautier E, Salvi D, Kidri S, Godard A, Thauvin-Robinet C, Masurel A, Lehalle D, Jean-Marçais N, Thevenon J, Lesca G, Putoux A, Cordier MP, Dupuis-Girod S, Till M, Duffourd Y, Rivière JB, Joly L, Juif C, Putois O, Ancet P, Lapointe AS, Morin P, Edery P, Rossi M, Sanlaville D, Béjean S, Peyron C, Faivre L. Exome sequencing in clinical settings: preferences and experiences of parents of children with rare diseases (SEQUAPRE study). Eur J Hum Genet 2019;27:701-10. [PMID: 30710147 DOI: 10.1038/s41431-018-0332-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
24 Koriath CAM, Kenny J, Ryan NS, Rohrer JD, Schott JM, Houlden H, Fox NC, Tabrizi SJ, Mead S. Genetic testing in dementia - utility and clinical strategies. Nat Rev Neurol 2021;17:23-36. [PMID: 33168964 DOI: 10.1038/s41582-020-00416-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
25 Ayuso C, Millan JM, Dal-re R. Management and return of incidental genomic findings in clinical trials. Pharmacogenomics J 2015;15:1-5. [DOI: 10.1038/tpj.2014.62] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
26 Ormond KE, O'daniel JM, Kalia SS. Secondary findings: How did we get here, and where are we going? J Genet Couns 2019;28:326-33. [DOI: 10.1002/jgc4.1098] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
27 Tolusso LK, Collins K, Zhang X, Holle JR, Valencia CA, Myers MF. Pediatric Whole Exome Sequencing: an Assessment of Parents’ Perceived and Actual Understanding. J Genet Counsel 2017;26:792-805. [DOI: 10.1007/s10897-016-0052-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
28 Christensen KD, Bernhardt BA, Jarvik GP, Hindorff LA, Ou J, Biswas S, Powell BC, Grundmeier RW, Machini K, Karavite DJ, Pennington JW, Krantz ID, Berg JS, Goddard KAB. Anticipated responses of early adopter genetic specialists and nongenetic specialists to unsolicited genomic secondary findings. Genet Med 2018;20:1186-95. [PMID: 29388940 DOI: 10.1038/gim.2017.243] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
29 Braverman G, Shapiro ZE, Bernstein JA. Ethical Issues in Contemporary Clinical Genetics. Mayo Clin Proc Innov Qual Outcomes 2018;2:81-90. [PMID: 30225437 DOI: 10.1016/j.mayocpiqo.2018.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
30 Balicza P, Terebessy A, Grosz Z, Varga NA, Gal A, Fekete BA, Molnar MJ. Implementation of personalized medicine in Central-Eastern Europe: pitfalls and potentials based on citizen's attitude. EPMA J 2018;9:103-12. [PMID: 29515690 DOI: 10.1007/s13167-017-0125-3] [Reference Citation Analysis]
31 Wilson BJ, Nicholls SG. The Human Genome Project, and recent advances in personalized genomics. Risk Manag Healthc Policy. 2015;8:9-20. [PMID: 25733939 DOI: 10.2147/rmhp.s58728] [Cited by in Crossref: 39] [Cited by in F6Publishing: 14] [Article Influence: 5.6] [Reference Citation Analysis]
32 Cheung F, Birch P, Friedman JM, Elliott AM, Adam S; CAUSES Study, GenCOUNSEL Study. The long‐term impact of receiving incidental findings on parents undergoing genome‐wide sequencing. Journal of Genetic Counseling. [DOI: 10.1002/jgc4.1558] [Reference Citation Analysis]
33 Hallowell N, Hall A, Alberg C, Zimmern R. Revealing the results of whole-genome sequencing and whole-exome sequencing in research and clinical investigations: some ethical issues. J Med Ethics 2015;41:317-21. [PMID: 25038088 DOI: 10.1136/medethics-2013-101996] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
34 Delanne J, Nambot S, Chassagne A, Putois O, Pelissier A, Peyron C, Gautier E, Thevenon J, Cretin E, Bruel AL, Goussot V, Ghiringhelli F, Boidot R, Tran Mau-Them F, Philippe C, Vitobello A, Demougeot L, Vernin C, Lapointe AS, Bardou M, Luu M, Binquet C, Lejeune C, Joly L, Juif C, Baurand A, Sawka C, Bertolone G, Duffourd Y, Sanlaville D, Pujol P, Geneviève D, Houdayer F, Thauvin-Robinet C, Faivre L. Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature. Eur J Med Genet 2019;62:103529. [PMID: 30165243 DOI: 10.1016/j.ejmg.2018.08.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
35 Smith ED, Blanco K, Sajan SA, Hunter JM, Shinde DN, Wayburn B, Rossi M, Huang J, Stevens CA, Muss C, Alcaraz W, Hagman KDF, Tang S, Radtke K. A retrospective review of multiple findings in diagnostic exome sequencing: half are distinct and half are overlapping diagnoses. Genet Med 2019;21:2199-207. [PMID: 30894705 DOI: 10.1038/s41436-019-0477-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
36 Cornelis C, Tibben A, Dondorp W, van Haelst M, Bredenoord AL, Knoers N, Düwell M, Bolt I, van Summeren M. Whole-exome sequencing in pediatrics: parents' considerations toward return of unsolicited findings for their child. Eur J Hum Genet 2016;24:1681-7. [PMID: 27460421 DOI: 10.1038/ejhg.2016.100] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
37 Niguidula N, Alamillo C, Shahmirzadi Mowlavi L, Powis Z, Cohen JS, Farwell Hagman KD. Clinical whole-exome sequencing results impact medical management. Mol Genet Genomic Med 2018;6:1068-78. [PMID: 30318729 DOI: 10.1002/mgg3.484] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
38 Neu MB, Bowling KM, Cooper GM. Clinical utility of genomic sequencing. Curr Opin Pediatr 2019;31:732-8. [PMID: 31693580 DOI: 10.1097/MOP.0000000000000815] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
39 Martyn M, Kanga-parabia A, Lynch E, James PA, Macciocca I, Trainer AH, Halliday J, Keogh L, Wale J, Winship I, Bogwitz M, Valente G, Walsh M, Downie L, Amor D, Wallis M, Cunningham F, Burgess M, Brown NJ, Jarmolowicz A, Lunke S, Goranitis I, Gaff CL; Melbourne Genomics Health Alliance. A novel approach to offering additional genomic findings-A protocol to test a two-step approach in the healthcare system. J Genet Couns 2019;28:388-97. [DOI: 10.1002/jgc4.1102] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
40 Loud JT, Bremer RC, Mai PL, Peters JA, Giri N, Stewart DR, Greene MH, Alter BP, Savage SA. Research participant interest in primary, secondary, and incidental genomic findings. Genet Med 2016;18:1218-25. [PMID: 27101135 DOI: 10.1038/gim.2016.36] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
41 Rego S, Grove ME, Cho MK, Ormond KE. Informed Consent in the Genomics Era. Cold Spring Harb Perspect Med 2020;10:a036582. [PMID: 31570382 DOI: 10.1101/cshperspect.a036582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Groopman EE, Rasouly HM, Gharavi AG. Genomic medicine for kidney disease. Nat Rev Nephrol 2018;14:83-104. [PMID: 29307893 DOI: 10.1038/nrneph.2017.167] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 12.5] [Reference Citation Analysis]
43 Ewuoso C. A Systematic Review of the Management of Incidental Findings in Genomic Research. BEOnline 2016;3:1-21. [PMID: 28361093 DOI: 10.20541/beonline.2016.0006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
44 Bick D, Fraser PC, Gutzeit MF, Harris JM, Hambuch TM, Helbling DC, Jacob HJ, Kersten JN, Leuthner SR, May T, North PE, Prisco SZ, Schuler BA, Shimoyama M, Strong KA, Van Why SK, Veith R, Verbsky J, Weborg AM Jr, Wilk BM, Willoughby RE Jr, Worthey EA, Dimmock DP. Successful Application of Whole Genome Sequencing in a Medical Genetics Clinic. J Pediatr Genet 2017;6:61-76. [PMID: 28496993 DOI: 10.1055/s-0036-1593968] [Cited by in Crossref: 3] [Cited by in F6Publishing: 27] [Article Influence: 0.5] [Reference Citation Analysis]
45 Barajas M, Ross LF. Pediatric Professionals' Attitudes about Secondary Findings in Genomic Sequencing of Children. The Journal of Pediatrics 2015;166:1276-1282.e7. [DOI: 10.1016/j.jpeds.2015.01.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
46 Ireland D, Bradford D, Szepe E, Lynch E, Martyn M, Hansen D, Gaff C. Introducing Edna: A trainee chatbot designed to support communication about additional (secondary) genomic findings. Patient Educ Couns 2021;104:739-49. [PMID: 33234441 DOI: 10.1016/j.pec.2020.11.007] [Reference Citation Analysis]
47 van den Veyver IB, Eng CM. Genome-Wide Sequencing for Prenatal Detection of Fetal Single-Gene Disorders. Cold Spring Harb Perspect Med 2015;5:a023077. [PMID: 26253094 DOI: 10.1101/cshperspect.a023077] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
48 Pal LR, Kundu K, Yin Y, Moult J. CAGI4 SickKids clinical genomes challenge: A pipeline for identifying pathogenic variants. Hum Mutat 2017;38:1169-81. [PMID: 28512736 DOI: 10.1002/humu.23257] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
49 Meiser B, Storey B, Quinn V, Rahman B, Andrews L. Acceptability of, and Information Needs Regarding, Next-Generation Sequencing in People Tested for Hereditary Cancer: A Qualitative Study. J Genet Couns 2016;25:218-27. [PMID: 26259529 DOI: 10.1007/s10897-015-9861-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
50 O'Neill SC, Tercyak KP, Baytop C, Hensley Alford S, McBride CM. A new approach to assessing affect and the emotional implications of personal genomic testing for common disease risk. Public Health Genomics 2015;18:104-12. [PMID: 25612474 DOI: 10.1159/000370101] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
51 Bishop C, Strong K, Dimmock D. Choices of incidental findings of individuals undergoing genome wide sequencing, a single center's experience: Choices of incidental findings of individuals undergoing genome wide sequencing. Clin Genet 2017;91:137-40. [DOI: 10.1111/cge.12829] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
52 Amendola LM, Robinson JO, Hart R, Biswas S, Lee K, Bernhardt BA, East K, Gilmore MJ, Kauffman TL, Lewis KL, Roche M, Scollon S, Wynn J, Blout C. Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium. J Genet Couns 2018;27:1220-7. [PMID: 29497922 DOI: 10.1007/s10897-018-0243-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
53 Yang M, Kim JW. Principles of Genetic Counseling in the Era of Next-Generation Sequencing. Ann Lab Med 2018;38:291-5. [PMID: 29611378 DOI: 10.3343/alm.2018.38.4.291] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
54 Souzeau E, Burdon KP, Mackey DA, Hewitt AW, Savarirayan R, Otlowski M, Craig JE. Ethical Considerations for the Return of Incidental Findings in Ophthalmic Genomic Research. Transl Vis Sci Technol 2016;5:3. [PMID: 26929883 DOI: 10.1167/tvst.5.1.3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
55 Saelaert M, Mertes H, Moerenhout T, Van Cauwenbergh C, Leroy BP, Devisch I, De Baere E. A qualitative study among patients with an inherited retinal disease on the meaning of genomic unsolicited findings. Sci Rep 2021;11:15834. [PMID: 34349199 DOI: 10.1038/s41598-021-95258-2] [Reference Citation Analysis]
56 Hoell C, Wynn J, Rasmussen LV, Marsolo K, Aufox SA, Chung WK, Connolly JJ, Freimuth RR, Kochan D, Hakonarson H, Harr M, Holm IA, Kullo IJ, Lammers PE, Leppig KA, Leslie ND, Myers MF, Sharp RR, Smith ME, Prows CA. Participant choices for return of genomic results in the eMERGE Network. Genet Med 2020;22:1821-9. [PMID: 32669677 DOI: 10.1038/s41436-020-0905-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
57 Bijlsma RM, Wouters RHP, Wessels H, May AM, Ausems MGEM, Voest EE, Bredenoord AL. Managing unsolicited findings in genomics: A qualitative interview study with cancer patients. Psychooncology 2018;27:1327-33. [PMID: 29471587 DOI: 10.1002/pon.4676] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
58 Fiallos K, Applegate C, Mathews DJ, Bollinger J, Bergner AL, James CA. Choices for return of primary and secondary genomic research results of 790 members of families with Mendelian disease. Eur J Hum Genet 2017;25:530-7. [PMID: 28272539 DOI: 10.1038/ejhg.2017.21] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
59 Smith LA, Douglas J, Braxton AA, Kramer K. Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling. J Genet Couns 2015;24:654-62. [PMID: 25403901 DOI: 10.1007/s10897-014-9794-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
60 Jelsig AM, Qvist N, Brusgaard K, Ousager LB. Research participants in NGS studies want to know about incidental findings. Eur J Hum Genet 2015;23:1423-6. [PMID: 25604854 DOI: 10.1038/ejhg.2014.298] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
61 Shkedi-Rafid S, Dheensa S, Crawford G, Fenwick A, Lucassen A. Defining and managing incidental findings in genetic and genomic practice. J Med Genet 2014;51:715-23. [PMID: 25228303 DOI: 10.1136/jmedgenet-2014-102435] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
62 Mackley MP, Fletcher B, Parker M, Watkins H, Ormondroyd E. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies. Genet Med 2017;19:283-93. [PMID: 27584911 DOI: 10.1038/gim.2016.109] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 12.3] [Reference Citation Analysis]
63 Bijlsma RM, Wessels H, Wouters RHP, May AM, Ausems MGEM, Voest EE, Bredenoord AL. Cancer patients' intentions towards receiving unsolicited genetic information obtained using next-generation sequencing. Fam Cancer 2018;17:309-16. [PMID: 28852913 DOI: 10.1007/s10689-017-0033-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
64 Macklin S, Laney D, Lisi E, Atherton A, Smith E. The Psychosocial Impact of Carrying a Debated Variant in the GLA Gene. J Genet Counsel 2018;27:217-24. [DOI: 10.1007/s10897-017-0139-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
65 Thompson ML, Finnila CR, Bowling KM, Brothers KB, Neu MB, Amaral MD, Hiatt SM, East KM, Gray DE, Lawlor JMJ, Kelley WV, Lose EJ, Rich CA, Simmons S, Levy SE, Myers RM, Barsh GS, Bebin EM, Cooper GM. Genomic sequencing identifies secondary findings in a cohort of parent study participants. Genet Med 2018;20:1635-43. [PMID: 29790872 DOI: 10.1038/gim.2018.53] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
66 Hylind R, Smith M, Rasmussen-Torvik L, Aufox S. Great expectations: patient perspectives and anticipated utility of non-diagnostic genomic-sequencing results. J Community Genet 2018;9:19-26. [PMID: 28656483 DOI: 10.1007/s12687-017-0314-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
67 Meiser B, Butow P, Davies G, Napier CE, Schlub TE, Bartley N, Juraskova I, Ballinger ML, Thomas DM, Best MC; members of the Psychosocial Issues in Genomics in Oncology (PiGeOn) Project. Psychological predictors of cancer patients' and their relatives' attitudes towards the return of genomic sequencing results. Eur J Med Genet 2022;:104516. [PMID: 35487418 DOI: 10.1016/j.ejmg.2022.104516] [Reference Citation Analysis]
68 Rini C, Khan CM, Moore E, Roche MI, Evans JP, Berg JS, Powell BC, Corbie-Smith G, Foreman AKM, Griesemer I, Lee K, O'Daniel JM, Henderson GE. The who, what, and why of research participants' intentions to request a broad range of secondary findings in a diagnostic genomic sequencing study. Genet Med 2018;20:760-9. [PMID: 29261173 DOI: 10.1038/gim.2017.176] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
69 Tibben A, Dondorp W, Cornelis C, Knoers N, Brilstra E, van Summeren M, Bolt I. Parents, their children, whole exome sequencing and unsolicited findings: growing towards the child's future autonomy. Eur J Hum Genet 2021;29:911-9. [PMID: 33456055 DOI: 10.1038/s41431-020-00794-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
70 Lohmann K, Klein C. Next generation sequencing and the future of genetic diagnosis. Neurotherapeutics 2014;11:699-707. [PMID: 25052068 DOI: 10.1007/s13311-014-0288-8] [Cited by in Crossref: 89] [Cited by in F6Publishing: 71] [Article Influence: 12.7] [Reference Citation Analysis]
71 Peyron C, Pélissier A, Béjean S. Preference heterogeneity with respect to whole genome sequencing. A discrete choice experiment among parents of children with rare genetic diseases. Social Science & Medicine 2018;214:125-32. [DOI: 10.1016/j.socscimed.2018.08.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
72 Yu JH, Appelbaum PS, Brothers KB, Joffe S, Kauffman TL, Koenig BA, Prince AE, Scollon S, Wolf SM, Bernhardt BA, Wilfond BS; Clinical Sequencing Exploratory Research (CSER) Consortium Informed Consent and Governance Working Group. Consent for clinical genome sequencing: considerations from the Clinical Sequencing Exploratory Research Consortium. Per Med 2019;16:325-33. [PMID: 31313633 DOI: 10.2217/pme-2018-0076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
73 Blasimme A, Moret C, Hurst SA, Vayena E. Informed Consent and the Disclosure of Clinical Results to Research Participants. Am J Bioeth 2017;17:58-60. [PMID: 28661744 DOI: 10.1080/15265161.2017.1328532] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]